TrialTrials2017

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial.

Amy Cranston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.